Martin Linhult
CMC Lead at Diamyd Medical- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Diamyd Medical
-
Sweden
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
CMC Lead
-
Jun 2023 - Present
-
-
-
CombiGene
-
Sweden
-
Biotechnology Research
-
1 - 100 Employee
-
Director CMC
-
Dec 2020 - Jun 2023
-
-
-
Chiesi Group
-
Italy
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Technical leader
-
Jul 2018 - Dec 2020
-
-
-
Octapharma
-
Switzerland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
-
Jan 2013 - Jun 2018
Responsible for clinical/commercial recombinant production with mammalian cells.
-
-
-
Apr 2010 - Jan 2013
-
-
-
Oct 2009 - Apr 2010
-
-
-
Dec 2004 - Oct 2009
Working in a pilot plant with downstream processes to initiate and upscaling of recombinant products.
-
-
-
Kungliga tekniska högskolan
-
Spectator Sports
-
1 - 100 Employee
-
PhD candidate
-
Jan 1998 - Jun 2004
Development of different affinity ligands. During my PhD I tried to improve different affinity ligands for large scale applications. The work included several different techniques, such as PCR, expression, purification and protein characterisation. Development of different affinity ligands. During my PhD I tried to improve different affinity ligands for large scale applications. The work included several different techniques, such as PCR, expression, purification and protein characterisation.
-
-
Education
-
KTH Royal Institute of Technology
PhD, Molecular Biotechnology -
KTH Royal Institute of Technology
Master, Chemsitry -
Uppsala University